🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

GLP-1 obesity drugs - such as $NVO Ozempic & Wegovy and $LLY Zepbound & Mounjaro have long became a household name - making Obesity the fastest growing market in BioTech. This excellent 📊👇- by Stifel’s Tim Opler, describes the current obesity RNAi therapeutic landscape! $XBI

Here is my favourite weekly 🧵- made by my dear friend BiopharmIQ by Amp - which is a comprehensive recap of the past week in BioTech. This 🧵 gathers the best BioTech posts written by some of the best & brightest 𝕏 BioTwitter accounts - all into one place. Do give him a follow. $XBI

IMO the most amazing thing that X provides us is the ability to make new friends that otherwise we wouldn’t have a chance to meet. So thank you Biotech2k my dear & close friend for this amazing shoutout and for all of your support & endorsement! I really appreciate it! 🙏

It’s heartbreaking to hear David R. Liu - the winner of the 2025 Breakthrough Prize in Life Sciences and one of the top leading scientists & innovators of our lifetime, describes during his conversation with Walter Isaacson the irreversible damages and the crisis caused from the

You are a must follow in my book Yair Einhorn .

Great figure from Oppenheimer team on The China Trade 🇨🇳

🚨! Prime Medicine’s CSO - Jeremy Duffield is stepping down as the Chief Scientific Officer of $PRME - effective of July 15, 2025 which means immediately. He will continue to provide consulting & advisory services until March 31, 2026. CSO leaving is never a good sign. $XBI